1. A pharmaceutical composition for use in the treatment of HIV or AIDS, comprising a solid dosage form comprising: (i) a first granule (granules) comprising ritonavir or a pharmaceutically acceptable salt thereof, an ester or solvate, and a water-insoluble polymer and / or soluble a polymer in water； (ii) a second granule (s) comprising darunavir or a pharmaceutically acceptable salt, ester or solvate thereof. 2. The pharmaceutical composition of claim 1, wherein the dosage form is a capsule or sachet containing said first granule (granules) and a second granule (granules). The pharmaceutical composition of claim 1, wherein the ritonavir solvate is ritonavir hydrate. The pharmaceutical composition of claim 1, wherein the darunavir solvate is darunavir hydrate. A pharmaceutical composition for use in the treatment of HIV or AIDS, comprising a solid dosage form comprising: (i) a first tablet (s) comprising ritonavir or a pharmaceutically acceptable salt thereof, an ester or solvate, and a water-insoluble polymer and / or water-soluble polymer； (ii) a second tablet (s) comprising darunavir or a pharmaceutically acceptable salt, ester or solvate thereof. 6. The pharmaceutical composition of claim 5, wherein the first tablet (s) and the second tablet (s) are placed in a capsule or sachet. The pharmaceutical composition of claim 5, wherein the ritonavir solvate is ritonavir hydrate. The pharmaceutical composition of claim 5, wherein the darunavir solvate is darunavir hydrate. A pharmaceutical composition for use in the treatment of HIV or AIDS, comprising a solid dosage form, including1. Фармацевтическая композиция для применения в лечении HIV или AIDS, включающая твердую лекарственную форму, включающую:(i) первую гранулу (гранулы), включающую ритонавир или его фармацевтически приемлемую соль, сложный эфир или сольват, и нерастворимый в воде полимер и/или растворимый в воде полимер；(ii) вторую гранулу (гранулы), включающую дарунавир или его фармацевтически приемлемую сол
